FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

LOTUSEYE Share Price Discussion

Lotus Eye Hospital and Institute Ltd.
Sector: Pharmaceuticals and health care
... Read more
LOTUSEYE Share Price *
22.8 +0.8 (3.64%)
* (quote may be delayed)

Find answers to all your questions on live LOTUSEYE message board: Is LOTUSEYE buy or sell? Should I buy LOTUSEYE shares? Why are LOTUSEYE shares falling? Should I invest in LOTUSEYE stock?

LOTUSEYE Discussion Forum

  • LOTUSEYE - Share Price - Fundamentals

    Market Capitalization46.07
    Enterprise Value43.57
    Price to Earnings33.22
    Price to Book Value0.92
    Return on Capital Employed0.04
    Return on Equity0.03
    Face Value10
    Dividend Yield0.02
  • LOTUSEYE Share Price - Technicals

    LOTUSEYE - 52 Week High₹30
    LOTUSEYE - 52 Week Low₹15.55
  • LOTUSEYE Share Price - Historical (₹)

    Dec 923.8524.320.722.3
    Dec 62323.921.5522
    Dec 5232321.8522.95
    Dec 422.6523.922.123
    Dec 322.852422.522.85
  • LOTUSEYE Share Price - Daily Moving Averages (DMA)

    20 Day Moving Average₹22.74
    30 Day Moving Average₹21.89
    50 Day Moving Average₹21.81
    100 Day Moving Average₹20.69
    200 Day Moving Average₹21
  • LOTUSEYE - Profit And Loss

    CONSOLIDATEDMar-18Mar-17 % Change
    Operating Profit4.343.290.32
    Profit Before Tax1.70.43.25
    Net Income1.750.433.07
  • LOTUSEYE - Balance Sheet

    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds50.1250.64-0.01
    Total Liabilities6.537.57-0.14
    Total Assets56.6558.21-0.03
  • LOTUSEYE - Cash Flow

    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity5.783.720.55
    Cash from Investing Activity-3.86-1.092.54
    Cash from Financing Activity-1.51-0.1211.58
    Net Cash Flow0.412.51-0.84
  • LOTUSEYE - Ratios

    Return on Assets0.030.01
    Return on Equity0.030.01
    Return on Capital Employed0.040.01
  • LOTUSEYE - 3 year Growth

    3 Year CAGR Growth in Revenue0.27
    3 Year CAGR Growth in Operating Profit0.98
    3 Year CAGR Growth in EBIDTA0.09
    3 Year CAGR Growth in Net Income1.88
    3 Yr CAGR Growth - Diluted EPS1.88
  • LOTUSEYE - 5 year Growth

    5 Year CAGR Growth in Revenue0.31
    5 Year CAGR Growth in Operating Profit0.21
    5 Year CAGR Growth in EBIDTA1.05
    5 Year CAGR Growth in Net Income3.17
    3 Yr CAGR Growth - Diluted EPS3.2
  • LOTUSEYE - Recent News

  • LOTUSEYE - Related Communities

    Sakar Healthcare Ltd. Sector: Pharmac...
    Metropolis Healthcare Ltd. Sector: Ph...
    Vimta Labs Ltd. Sector: Pharmaceutica...
    Thyrocare Technologies Ltd. Sector: P...
    Shalby Ltd. Sector: Pharmaceuticals a...
    Narayana Hrudayalaya Ltd. Sector: Pha...
    Lotus Eye Hospital and Institute Ltd....
    Dr. Lal Pathlabs Ltd. Sector: Pharmac...
    Indraprastha Medical Corporation Ltd....
    Healthcare Global Enterprises Ltd. Se...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.